Cziraky, Mark J <br/><br/>
Risk of hospitalized rhabdomyolysis associated with lipid-lowering drugs in a real-world clinical setting.  [electronic resource] 

 -  Journal of clinical lipidology   
 - 102-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1933-2874 
<br/><br/><label>Standard No.: </label>10.1016/j.jacl.2012.06.006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Atorvastatin<br/>Cohort Studies<br/>Female<br/>Fenofibrate--adverse effects<br/>Follow-Up Studies<br/>Gemfibrozil--adverse effects<br/>Heptanoic Acids--adverse effects<br/>Hospitalization<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--adverse effects<br/>Hypoglycemia--drug therapy<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Niacin--adverse effects<br/>Odds Ratio<br/>Pyridines--adverse effects<br/>Pyrroles--adverse effects<br/>Rhabdomyolysis--epidemiology<br/>Risk Factors